Diagnostic accuracy of interleukin-2 receptor in sarcoidosis: a systematic review and meta-analysis

References

• Thomas KW, Hunninghake GW. Sarcoidosis. JAMA. 2003 Jun 25;289(24):3300–3303.
   PubMed Web of Science ®Google Scholar
• Arkema EV, Cozier YC. Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors. Curr Opin Pulm Med. 2020 Sep;26(5):527–534. doi: 10.1097/MCP.0000000000000715
   PubMed Web of Science ®Google Scholar
• Cummings MM, Dunner E, Schmidt RH Jr., et al. Concepts of epidemiology of sarcoidosis; preliminary report of 1,194 cases reviewed with special reference to geographic ecology. Postgrad Med. 1956 May;19(5):437–446.
   PubMedGoogle Scholar
• Sartwell PE, Edwards LB. Epidemiology of sarcoidosis in the U.S. Navy. Am J Epidemiol. 1974 Apr;99(4):250–257. doi: 10.1093/oxfordjournals.aje.a121609
   PubMed Web of Science ®Google Scholar
• Crouser ED, Maier LA, Wilson KC, et al. Diagnosis and detection of sarcoidosis. An official American thoracic society clinical practice guideline. Am J Respir Crit Care Med. 2020 Apr 15;201(8):e26–e51. doi: 10.1164/rccm.202002-0251ST
   PubMed Web of Science ®Google Scholar
• El Jammal T, Jamilloux Y, Gerfaud-Valentin M, et al. Challenging mimickers in the diagnosis of sarcoidosis: a case study. Diagnostics. 2021 Jul 12;11(7):1240. doi: 10.3390/diagnostics11071240
   Web of Science ®Google Scholar
• Uysal P, Durmus S, Sozer V, et al. YKL-40, soluble IL-2 receptor, angiotensin converting enzyme and C-Reactive protein: comparison of markers of sarcoidosis activity. Biomolecules. 2018 Aug 28;8(3):84. doi: 10.3390/biom8030084
   PubMed Web of Science ®Google Scholar
• Schimmelpennink MC, Quanjel M, Vorselaars A, et al. Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis. Expert Rev Respir Med. 2020 Jul;14(7):749–756.
   PubMed Web of Science ®Google Scholar
• Vorselaars AD, van Moorsel CH, Zanen P, et al. ACE and Sil-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy. Respir med. 2015 Feb;109(2):279–285.
   PubMed Web of Science ®Google Scholar
• Terrington DL, Kim JW, Ravenhill G, et al. Soluble interleukin-2 receptor in exhaled breath condensate in pulmonary sarcoidosis: a cross-sectional pilot study. J Breath Res. 2020 Dec 18;15(1):016016. doi: 10.1088/1752-7163/abb763
   PubMed Web of Science ®Google Scholar
• van Stigt AC, Dalm V, Nagtzaam NMA, et al. Soluble interleukin-2 receptor is a promising serum biomarker for granulomatous disease in common variable immune deficiency. J Clin Immunol. 2021 Apr;41(3):694–697. doi: 10.1007/s10875-020-00947-8
   PubMed Web of Science ®Google Scholar
• Gause S, Neto MLR, Culver DA, editors. Assessing the clinical utility of serum angiotensin-converting enzyme, soluble IL-2 receptor, and 1-25 vitamin D in the diagnosis of extra-pulmonary sarcoidosis. American Thoracic Society 2019 International Conference. 2019 May 17–22;Dallas, TX.
   Google Scholar
• Dik WA, Heron M. Clinical significance of soluble interleukin-2 receptor measurement in immune-mediated diseases. Neth J Med. 2020 Sep;78(5):220–231.
   PubMed Web of Science ®Google Scholar
• Grutters JC, Fellrath JM, Mulder L, et al. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation. Chest. 2003 Jul;124(1):186–195.
   PubMed Web of Science ®Google Scholar
• Gungor S, Ozseker F, Yalcinsoy M, et al. Conventional markers in determination of activity of sarcoidosis. Int Immunopharmacol. 2015 Mar;25(1):174–179.
   PubMed Web of Science ®Google Scholar
• Prasse A, Katic C, Germann M, et al. Phenotyping sarcoidosis from a pulmonary perspective. Am J Respir Crit Care Med. 2008 Feb 1;177(3):330–336. doi: 10.1164/rccm.200705-742OC
   PubMed Web of Science ®Google Scholar
• Gundlach E, Hoffmann MM, Prasse A, et al. Interleukin-2 receptor and angiotensin-converting enzyme as markers for ocular sarcoidosis. PLoS One. 2016;11(1):e0147258. doi: 10.1371/journal.pone.0147258
   PubMed Web of Science ®Google Scholar
• Rothkrantz-Kos S, van Dieijen-Visser MP, Mulder PG, et al. Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis. Clin Chem. 2003 Sep;49(9):1510–1517.
   PubMed Web of Science ®Google Scholar
• Eurelings LEM, Miedema JR, Dalm V, et al. Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis. PLoS One. 2019;14(10):e0223897. doi: 10.1371/journal.pone.0223897
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol. 2021 Jun;134:178–189.
   PubMed Web of Science ®Google Scholar
• Bons JA, Drent M, Bouwman FG, et al. Potential biomarkers for diagnosis of sarcoidosis using proteomics in serum. Respir med. 2007 Aug;101(8):1687–1695.
   PubMed Web of Science ®Google Scholar
• Ishihara M, Meguro A, Ishido M, et al. Usefulness of combined measurement of serum soluble IL-2R and angiotensin-converting enzyme in the detection of uveitis associated with Japanese sarcoidosis. Clin Ophthalmol. 2020;14:2311–2317. doi: 10.2147/OPTH.S264595
   PubMed Web of Science ®Google Scholar
• Enyedi A, Csongradi A, Altorjay IT, et al. Combined application of angiotensin converting enzyme and chitotriosidase analysis improves the laboratory diagnosis of sarcoidosis. Clinica Chimica Acta. 2020 Jan;500:155–162.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Namba K, Mizuuchi K, et al. Validation of systemic parameters for the diagnosis of ocular sarcoidosis. Jpn J Ophthalmol. 2021 Mar;65(2):191–198.
   PubMed Web of Science ®Google Scholar
• Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011 Oct 18;155(8):529–536. doi: 10.7326/0003-4819-155-8-201110180-00009
   PubMed Web of Science ®Google Scholar
• Devillé WL, Buntinx F, Bouter LM, et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol. 2002 Jul 3;2(1):9. doi: 10.1186/1471-2288-2-9
   PubMedGoogle Scholar
• Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med. 1993 Jul 30;12(14):1293–1316. doi: 10.1002/sim.4780121403
   PubMed Web of Science ®Google Scholar
• Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005 Sep;58(9):882–893. doi: 10.1016/j.jclinepi.2005.01.016
   PubMed Web of Science ®Google Scholar
• Groen-Hakan F, Eurelings L, ten Berge JC, et al. Diagnostic value of serum-soluble interleukin 2 receptor levels vs angiotensin-converting enzyme in patients with sarcoidosis-associated uveitis. JAMA Ophthalmol. 2017 Dec 1;135(12):1352–1358. doi: 10.1001/jamaophthalmol.2017.4771
   PubMed Web of Science ®Google Scholar
• Hong Nguyen C T, Kambe N, Kishimoto I, et al. Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement. J Dermatol. 2017 Jul;44(7):789–797. doi: 10.1111/1346-8138.13792
   PubMed Web of Science ®Google Scholar
• Sunaga N, Koga Y, Hachisu Y, et al. Role of neuron-specific enolase in the diagnosis and disease monitoring of sarcoidosis. Can Respir J. 2022;2022:1–9. doi: 10.1155/2022/3726395
   Web of Science ®Google Scholar
• Unal M, Janssen A, Vries LAM, et al. The value of serum Sil-2R and 18F-FDG-PET/CT for the diagnosis of Ocular sarcoïdosis in patients with Uveitis. 2018;1(01):1.
   Google Scholar
• Costabel U, Hunninghake GW, Behalf of the Sarcoidosis Statement Committee ON. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis statement committee. American Thoracic society. European respiratory society. World association for sarcoidosis and other granulomatous disorders. Eur Respir J. 1999 Oct;14(4):735–737. doi: 10.1034/j.1399-3003.1999.14d02.x
   PubMedGoogle Scholar
• Mochizuki M, Smith JR, Takase H, et al. Revised criteria of international workshop on ocular sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol. 2019 Oct;103(10):1418–1422.
   PubMed Web of Science ®Google Scholar
• Sève P, Pacheco Y, Durupt F, et al. Sarcoidosis: a clinical overview from symptoms to diagnosis. Cells. 2021 Mar 31;10(4):766. doi: 10.3390/cells10040766
   PubMed Web of Science ®Google Scholar
• Sève P, Jamilloux Y, Tilikete C, et al. Ocular sarcoidosis. Semin Respir Crit Care Med. 2020 Oct;41(5):673–688.
   PubMedGoogle Scholar
• Febvay C, Kodjikian L, Maucort-Boulch D, et al. Clinical features and diagnostic evaluation of 83 biopsy-proven sarcoid uveitis cases. Br J Ophthalmol. 2015 Oct;99(10):1372–1376.
   PubMed Web of Science ®Google Scholar
• Miyoshi S, Hamada H, Kadowaki T, et al. Comparative evaluation of serum markers in pulmonary sarcoidosis. Chest. 2010 Jun;137(6):1391–1397.
   PubMed Web of Science ®Google Scholar
• Sugi K, Kaneda Y, Hirasawa K, et al. Radioisotope marking under CT guidance and localization using a handheld gamma probe for small or indistinct pulmonary lesions. Chest. 2003 Jul;124(1):155–158.
   PubMed Web of Science ®Google Scholar
• Keicho N, Kitamura K, Takaku F, et al. Serum concentration of soluble interleukin-2 receptor as a sensitive parameter of disease activity in sarcoidosis. Chest. 1990 Nov;98(5):1125–1129.
   PubMed Web of Science ®Google Scholar
• Vorselaars AD, Verwoerd A, van Moorsel CH, et al. Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis. Eur Respir J. 2014 Feb;43(2):602–609. doi: 10.1183/09031936.00055213
   PubMed Web of Science ®Google Scholar
• Ogata-Suetsugu S, Hamada N, Takayama K, et al. The clinical value of serum soluble interleukin-2 receptor in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(1):41–47. doi: 10.36141/svdld.v34i1.5045
   PubMed Web of Science ®Google Scholar
• Bargagli E, Bianchi N, Margollicci M, et al. Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity. Scand J Clin Lab Invest. 2008;68(6):479–483. doi: 10.1080/00365510701854975
   PubMed Web of Science ®Google Scholar
• Shen Y, Pang C, Wu Y, et al. Diagnostic performance of bronchoalveolar lavage fluid CD4/CD8 ratio for sarcoidosis: a meta-analysis. EBioMedicine. 2016 Jun;8:302–308.
   PubMed Web of Science ®Google Scholar
• Ramos-Casals M, Retamozo S, Sisó-Almirall A, et al. Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis. Expert Rev Clin Immunol. 2019 Apr;15(4):391–405.
   PubMed Web of Science ®Google Scholar
• Janot AC, Huscher D, Walker M, et al. Cigarette smoking and male sex are independent and age concomitant risk factors for the development of ocular sarcoidosis in a New Orleans sarcoidosis population. Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jul 22;32(2):138–143.
   PubMed Web of Science ®Google Scholar